Congenital heart defects and disease: An epidemiological overview

Italian Journal of Pediatrics

Volumn 30, Issue 5, 2004, Pages 261-266

  Bosi, G ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Congenital heart defects; Epidemiology

Indexed keywords

CORTICOSTEROID; ENVIRONMENTAL CHEMICAL; HYDANTOIN; PHENOTHIAZINE; SOLVENT; TRIMETHADIONE;

AORTA COARCTATION; AORTA STENOSIS; AORTA VALVE STENOSIS; CONGENITAL HEART MALFORMATION; CONGESTIVE CARDIOMYOPATHY; EBSTEIN ANOMALY; ENVIRONMENTAL FACTOR; FALLOT TETRALOGY; GENETIC RISK; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; HYPOPLASTIC LEFT HEART SYNDROME; ITALY; LONG QT SYNDROME; LUNG ATRESIA; PATENT DUCTUS ARTERIOSUS; PREVALENCE; PULMONARY VALVE STENOSIS; REGISTER; REVIEW; TRICUSPID VALVE ATRESIA;

EID: 11144228655     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Kerrebijn KF. Incidence in infants and mortality from congenital malformations of the circulatory system. Acta Paediatr Scand 1966;55:316-20.
2. Mitchell SC, Korones SB, Berendes NW. Congenital heart disease in 56.109 births: incidence and natural history. Circulation 1971;37:323-32.
3. Campbell M. Incidence of cardiac malformations at birth and later and neonatal mortality. Br Heart J 1973;35:189-200.
4. Bound JP, Logan WF. Incidence of congenital heart disease in Blackpool 1957-1971. Br Heart J 1977;39:445-50.
5. Hoffman JIE, Christianson R. Congenital heart disease in a cohort of 19,502 births with long-trem follow-up. Am J Cardiol 1978;42:641-7.
6. Laursen HB. Some epidemiological aspects of congenital heart disease in Denmark. Acta Paediatr Scand 1980;69:619-24.
7. Stocker F, Arbenz U, Desbaillets P. Vorkamen und Verlauf angeborener Herzfehler im erstem Lebensjahr in der Schweiz. Paediat Fortbild Prax 1980;31:90-100.
8. Dickinson DF, Arnold R, Wilkinson JL. Congenital heart disease among 160,480 liveborn children in Liverpool 1960-1969. Implications for surgical treatment. Br Heart J 1981;46:55-62.
9. Pexieder T, Bloch D, Oestreicher D, Swiss Paediatric Cardiologists Group. Analysis of congenital heart disease in 1984 birth cohort. Eur J Epidemiol 1986;2:330-4.
10. Carlgren LE, Ericson A, Kallen B. Monitoring of congenital cardiac defects. Pediatr Cardiol 1987;8:247-56.
11. Hoffman JIE. Incidence, mortality and natural history. In: Anderson RH, Macartney FJ, Shineborne EA, Tynan M, eds. Pediatric Cardiology. London: Churchil Livingstone 1987, pp. 3-14.
12. Grabitz RG, Joffres MR, Collins-Nakai RL. Congenital heart disease: incidence in the first year of life. The Alberta Heritage Pediatric Cardiology Program Am J Epidemiol 1988;128:381-8.
13. Samanek M, Slavik Z, Zborilova B, Hrobonova V, Voriskova M, Skovranek J. Prevalence, treatment, and outcome of heart disease in live-born children: a prospective analysis of 91.823 live-born children. Pediatr Cardiol 1989;10:205-11.
14. Mayberry JC, Scott WA, Goldberg SH. increased birth prevalence of cardiac defects in Yuma, Arizona. J Am Coll Cardiol 1990;16:1696-700.
15. Fixler DE, Pastor P, Chamberlin M, Sigman E, Clayton WE. Trends in congenital heart disease in Dallas county births. Circulation 1990;81:137-42.
16. Ferencz C, Correa-Villasenor A. Epidemiology of cardiovascular malformations: the state of the art. Cardiol Young 1991;1:264-84.
17. Pradat P. Epidemiology of major congenital heart defects in Sweden 1981-1986. Epidemiol Community Health 1992;46:211-5.
18. Moller JH, Andersen RC. 7000 consecutive children with a cardiac malformation with 26-year to 37-year follow-up. Am J Cardiol 1992;70:661-7.
19. Ferencz C, Rubin JD, Loffredo CA, Magee CA. Epidemiology of congenital heart disease. The Baltimore-Washington Infant Study: Perspectives in Pediatric Cardiology, Vol 4. Mount Kisco: Futura Publishing Co. 1993.
20. Manetti A, Pollini I, Cecchi F, de Simone L, Cianciulli D, Carbone C, et al. Epidemiologia delle malformazioni cardio-vascolari. III. Prevalenza e decorso in 46.895 nati vivi alla Maternità di Careggi, Firenze, nel periodo 1975-1984. G Ital Cardiol 1993;23:145-52.
21. Bower C, Ramsay JM. Congenital heart disease: a 10 year cohort. J Paediatr Child Health 1994;30:414-8.
22. Haan E, Chan A, Byron-Scott R, Scott H. The South Australian Birth Defets Register, Annual Report 1993. Adelaide, South Australia: Women's and Children's Hospital 1995.
23. Pexieder T, Bloch D, EUROCAT Working Party on Congenital Heart Disease. EUROCAT Subproject on epidemiology of congenital heart disease: First analysis of the completed study. In: Clark EB, Markwald RR, Takao A, eds. Developmental Mechanisms of Heart Disease. Armonk, NY, Futura Publishing Co. 1995. pp. 655-678.
24. Hoffman JIE. Incidence of congenital heart disease: I. Postanatal incidence. Pediatr Cardiol 1995;16:103-13.
25. Bosi G, Scorrano M, Tosato G, Forini E, Chakrokh R, and the Working Party of the Italian Society of Pediatric Cardiology. The Italian Multicentric Study on epidemiology of congenital heart disease: first step of the analysis. Cardiol Young 1999;9:291-9.
26. Hoffmann JIE, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900.
27. th ed., MEDICODE Pub., Salt Lake City, UT 1996.
28. Fyler DC. Report of the New England regional infant cardiac program. Pediatrics 1980;65(Suppl):376-461.
29. Wren C, Richmond S, Donaldson L. Temporal variability in birth prevalence of cardiovascular malformations. Heart 2000;83:414-9.
30. Pexieder T, Bloch D, Ferencz C, Eurocat and BWIS. Standard definition of cardiovascular malformations (CVM) promote accuracy of regional comparisons. Circulation 1991;84:11-385.
31. Stoll C, Alembik A, Roth MP, Dott B, De Geeter B. Risk factors in congenital heart disease. Eur J Epidemiol 1989;5:382-91.
32. Ferencz C. On the birth prevalence of congenital heart disease. J Am Coll Cardiol 1990;16:1701-2.
33. Bosi G, Garani G, Scorrano M, Calzolari E, & the IMER Working Party. Temporal variability in birth prevalence of congenital heart defects as recorded by a general birth defects registry. J Pediatr 2003;142:690-8.
34. Calzolari E, Garani G, Cocchi G, Magnani C, Rivieri F, Neville A, et al. & IMER Working Group. Congenital heart defects: 15 years of experience of the Emilia-Romagna Registry (Italy). Eur J Epidem 2003;18:773-80.
35. Wilson PD, Correa-Villasenor A, Loffredo CA, Ferencz C. Temporal trends in prevalence of cardiovascular malformations in Maryland and the District of Columbia, 1981-1988. The Baltimore-Washington Infant Study Group. Epidemiology 1993;4:259-65.
36. Botto LD, Correa-Villasenor A, Erickson JD. Racial and Temporal variations in the prevalence of heart defects. Pediatrics 2001;107:E22.
37. Kuehl K, Loffredo CA, Ferencz C. Failure to diagnose congenital heart disease in infancy. Pediatrics 1999;103:743-7.
38. Roberts WC. The congenitally bicuspid aortic valve: a study of 85 autopsy cases. Am J Cardiol 1970;26:72-83.
39. Warth DC, King ME, Cohen JM, Tesoriero VL, Marcus E, Weyman AE. Prevalence of mitral valve prolapse in normal children. J Am Coll Cardiol 1985;5:1173-7.
40. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary artery anoamlies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes. J Am Coll Cardiol 2000;35:1493-501.
41. Samanek M, Voriskova M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol 1999;20:411-7.
42. Allan LD, Sharland GK, Milburn A, Lockhart SM, Groves AM, Anderson RH, et al. Prospective diagnosis of 1.006 consecutive cases of congenital heart disease in fetus. J Am Coll Card 1994;23:1452-8.
43. Stumpften I, Stumpflen A, Wimmer M, Bernaschek G. Effect of detailed echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disese. Lancet 1996;348:854-7.
44. Lin AE, Herring AH, Scharenberg Amstutz K, Westgate M-N, Lacro RV, Al-Jufan M, et al. Cardiovascular malformations: changes in prevalence and birth status, 1972-1990. Am J Med Gen 1999;84:102-10.
45. Strauss A, Toth B, Schwab B, Fuchshuber S, Schulze A, Netz H, et al. Prenatal diagnosis of congenital heart disease and neonatal outcome - a six years' experience. Eur J Med Res 2001;6:66-70.
46. Fesslova V, Villa L, Kustermann A. Long-term experience with the prenatal diagnosis of cardiac anomalies in a tertiary center. Ital Heart J 2003;4:855-64.
47. Colan SD, Spevak PJ, Parness IA, Nadas AS. Cardiomyopathies. In: Fyler DC, ed. Nadas' Pediatric Cardiology. Philadelphia: Hanley & Belfus 1992, pp. 329-361.
48. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994;330:913-9.
49. Yates RWM, Taylor JFN. Cardiomyopathies in infants and children. Current Paediat 1996;6:137-44.
50. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
51. Basso C, Nava A, Thiene G. Cardiomiopatia aritmogena. Roma: Società Italiana di Cardiologia "Monografie di Cardiologia" 2001.
52. Tein I, De Vivo DC, Bierman P, Pulver P, De Meirleir LJ, Cvitanovic-Sojat L, et al. Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res 1990;28:247-55.
53. Tanaka M, Ino H, Ohno K, Hattori W, Sato T, Ozawa T, et al. Mitochondrial mutation in fatal mitochondrial cardiomyopathy. Lancet 1990;336:1452-5.
54. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, et al. Prolongation of the QT interval and sudeden infant death syndrome. N Engl J Med 1998;338:1709-14.
55. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell'età pediatrica. Clin Pediat 1963;45:656-83.
56. Priori SG, Schwartz PJ, Napolitano C, Bloise R, Ronchetti E, Grillo M, et al. Risk startification In the Long-QT sindrome. N Engl J Med 2003;348:1866-74.
57. Priori SG, Napolitano C, Giordano U, Collisani G, Memmi M. Brugada sindrome and sudden cardiac death in children. Lancet 2000;355:808.
58. Brugada R, Hong K, Dumaine R, Cordeiro J, Gaita F, Borggrefe M, et al. Sudden death associated with shon-QT syndrome linked to mutations in HERG. Circulation 2004;109:30-5.
59. Goldmuntz E, Driscoll D, Budarf ML, Zachai EH, McDonald-McGinn DM, Biegel JA, et al. Microdelations of chromosomal region 22q11 in patients with congenital conotruncal defects. J Med Genet 1993;30:807-12.
60. Webber SA, Hatchewell E, Barber JCK, Daubeney PE, Crolla JA, Salmon AP, et al. Importance of microdeletions of chromosomal region 22qII as a cause of selected malformations of the ventricular outflow tracts and aortic arch: a three-years prospective study. J Pediatr 1996;129:26-32.
61. Amati F, Mari A, Digilio MC, Mingarelli R, Marino B, Giannotti A, et al. 22qII deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet 1995;95:479-82.
62. Li QY, Newbury-Ecob R, Terret J, Wilson DI, Curtis A, Yi CH, et al. Holt-Oram syndrome is caused by mutations in TBX5 a member of the Brachyury (T) gene family. Nat Genet 1997;15:21-9.
63. Basson CT, Solomon SD, Weissman B, MacRae CA, Poznanski AK, Prieto F, et al. Genetic heterogeneity of heart-hand syndromes. Circulation 1995;91:136-29.
64. Bosi G, Scorrano M, Sensi A. A trial septal defect type ostium secundum with and without prolonged atrioventricular conduction. In: Shumacher G, Sauer U, eds. Genetics of cardiopathies: New informations from molecular biology methods. Munich 1999, pp. 199-202.
65. Li QY, Brooke B, Davis EC, Mecham RP, Sorensen BB, Boak E, et al. Elastin is an essential determinant of arterial morphogenesis. Nature 1998;393:276-80.
66. Robinson PN, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet 2000;37:9-25.
67. Botto LD, Mulinare J, Erikson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet 2003;30:95-101.
68. Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet 2004;125:12-21.
69. Ferencz C, Boughman JA, Neil CA, Brenner JI, Perry LW and The Baltimore-Washington Infant Study Group. Epidemiology of cardiovascular malformations: questions of inheritance. J Am Coll Card 1989;14:756-63.
70. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. Genetics and environmental risk factors of major cardio-vascular malformations. The Baltimore Washington Infant Study, 1981-89. In: Perspectives in Pediatric Cardiology, Vol 5. Mount Kisco, NY: Futura Publishing Co; 1997.
71. Schiaffino S, Dallapiccola B, Di Lisi R. Molecular genetics of congenitasl heart disease. A problem of faulty septation. Circ Res 1999;84:247-9.
72. Woodrow Benson D. Advances in cardio-vascular genetics and embryology: role of transcription factors in congenital heart disease. Curr Opin Pediatr 2000;12:497-500.
73. Sturm AC. Cardiovascular genetics: are we there yet? J Med Genet 2004;41:321-3.
74. Gelb BD. Genetic basis of congenital heart disease. Curr Opin Cardiol 2004;19:110-5.
75. Ventola M, Rigon F, Caponnetto A, Boccacci S, Goulene K, Bosi G. Identification of potential arrhythmogenic conditions by neonatal EKG screening. XXXI-II Congresso SICP: Bologna 8-11/10/2003. Ital Heart J 2003;4(Suppl 5)5S (C7).